Combined Holdings of Adaptive Biotechnologies (ADPT) - Updated Daily
Liquid Biopsy
Key Statistics
Statistics
| ⚖️Weighting | 🧢Market Cap |
|---|---|
| 0.48% | $749.26m |
| 🏋️♀️Weight Rank Across All Funds | 🌏Country |
| 38 | 🇺🇸United States |
| 💳ARK Estimated Cost Average | 🎫ARK Ownership Percent |
$26.04 - ARKG | 7.8% |
| Description | |
|---|---|
| we are a commercial-stage, biotechnology organization located in the hot biotech locations of seattle, washington and south san francisco, ca. our world class scientists have invented a patent-pending technology that combines advances in high-throughput sequencing with state-of-the-art computer infrastructure to provide an in-depth analysis of the t- and b-cell repertoire, a specific and important part of the immune system. this information is driving the r&d community to support the fights against cancer, auto-immune disease, and much, much more. we're often asked to describe our company culture. it is very easy ... we're a hard working group of top-notch individuals who are passionate about wanting to make a difference in the world. we know our employees are our most valuable asset, and every employee’s contribution is appreciated. open communication and collaboration are always encouraged in every interaction throughout the organization. we have high expectations of ourselves, and | |
| Website | |
| https://www.adaptivebiotech.com |
Other ETFs That Hold ADPT
Research Notes and Commentary for ADPT
No Research Notes Found for ADPT